Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposome Bupivacaine for Postsurgical Analgesia in TKA
NCT01977339Phase 4Withdrawn
- Sponsor
- St. Luke's-Roosevelt Hospital Center
- Start
- May 2015
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bupivacaine in Persistent postsurgical pain (PPSP), sponsored by St. Luke's-Roosevelt Hospital Center. Planned start May 2015; status: withdrawn.
02
Drugs
bupivacaine
03
Conditions
Persistent postsurgical pain (PPSP)
Beyond the preview
Go deeper on NCT01977339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01977339.